by nathan@evernetco.com | Sep 10, 2023
Who We Are: EvolveImmune Therapeutics is a next-generation immunotherapy company pioneering a new class of precision cancer medicines to transform patient outcomes, compared to current solid tumor therapies. Our first-in-category biotherapeutic EVOLVE platform...
by nathan@evernetco.com | Jun 21, 2023
Who We Are: EvolveImmune Therapeutics is a next-generation immunotherapy platform company based in the Yale/New Haven biotechnology ecosystem with laboratories in Farmington and Branford, CT. EvolveImmune is harnessing its ‘Immunology First’ approach to...
by nathan@evernetco.com | Jun 21, 2023
Who We Are: EvolveImmune Therapeutics is a next-generation immunotherapy platform company based in the Yale/New Haven biotechnology ecosystem with laboratories in Farmington and Branford, CT. EvolveImmune is harnessing its ‘Immunology First’ approach to...
by nathan@evernetco.com | Feb 14, 2023
About EI EvolveImmune Therapeutics is a next-generation immunotherapy drug discovery and development company based in the Yale/New Haven biotechnology ecosystem with laboratories in Farmington and Branford, CT. EvolveImmune is leveraging a novel in vivo...
by nathan@evernetco.com | Jun 21, 2022
Senior Director, CMC Program lead, Biologic Drug Substance Process Development Who We Are: EvolveImmune Therapeutics is a next-generation immunotherapy platform company based in the Yale/New Haven biotechnology ecosystem with laboratories in Farmington and Branford,...
